FDA hearings in House could begin by last week of February; Bliley promises FDA reform.
This article was originally published in The Tan Sheet
Executive Summary
FDA HOUSE HEARINGS COULD BEGIN AS EARLY AS LAST WEEK IN FEBRUARY in the House Commerce/oversight subcommittee, full committee Chairman Rep. Thomas Bliley (R-Va.) said during an address to the National Committee for Quality Health Care Feb. 1 in Washington, D.C. Bliley vowed: "I promise you, this session in the Commerce Committee there will -- repeat, there will -- be reforms in the way FDA does business." The Senate Labor & Human Resources Committee is expecting to hold hearings on FDA by July ("The Tan Sheet" Jan. 30, In Brief).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning